| Literature DB >> 31445584 |
Anna Capasso1, Ariella Benigni2, Umberto Capitanio3, Farhad R Danesh4, Vincenzo Di Marzo5, Loreto Gesualdo6, Giuseppe Grandaliano7, Edgar A Jaimes8, Jolanta Malyszko9, Mark A Perazella10, Qi Qian11, Pierre Ronco12, Mitchell H Rosner13, Francesco Trepiccione14, Davide Viggiano15, Carmine Zoccali16, Giovambattista Capasso17.
Abstract
Onco-nephrology is an emerging field in medicine. Patients with cancer may suffer from kidney diseases because of the cancer itself and cancer-related therapy. It is critical for nephrologists to be knowledgeable of cancer biology and therapy in order to be fully integrated in the multidisciplinary team and optimally manage patients with cancer and kidney diseases. In a recent international meeting, the key issues in this challenging clinical interface were addressed, including many unresolved basic science questions, such as the high tumor incidence in kidney transplant recipients. To this end, 70 highly qualified faculty members were gathered from all over the world to discuss these issues in 8 plenary sessions, including 5 keynote lectures. In addition, 48 young nephrologists and oncologists were invited to present their original observations that were highlighted in 2 large poster sessions.Entities:
Keywords: acute kidney injury; cancer; chemotherapy; chronic kidney disease; nephrotoxicity; renal cell carcinoma
Mesh：
Year: 2019 PMID： 31445584 DOI： 10.1016/j.kint.2019.04.043
Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612